Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)
NCT00378378
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
127
Enrollment
INDUSTRY
Sponsor class
Conditions
Nasal Polyps
Interventions
DRUG:
Mometasone Furoate Nasal Spray (MFNS)
DRUG:
Placebo nasal spray
Sponsor
Organon and Co